Posted By:Mike HuckmanThis morning a little biotech company, Antigenics, announced that Russia has approved its kidney cancer drug Oncophage. It's the first so-called therapeutic cancer vaccine to win full-out approval anywhere in the world. Read More Topics:FDA | Stock Market | Medicine | Corporate News | PharmaceuticalsSectors:Biotechnology | Health Care Equipment and Services | Health Care | PharmaceuticalsCompanies:Favrille, Inc. | Vical Incorporated | Geron Corp | Cell Genesys Inc | Antigenics Inc. | Dendreon CorpMEDIA:PHOTO | VIDEOPermalink ...